Back

Results - Announcements

Sales rise 34.65% to Rs 58.56 crore

Jagsonpal Pharmaceuticals standalone net profit rises 85.35% in the March 2025 quarter

07-May-2025, 07:45
Net profit of Jagsonpal Pharmaceuticals rose 85.35% to Rs 6.58 crore in the quarter ended March 2025 as against Rs 3.55 crore during the previous quarter ended March 2024. Sales rose 34.65% to Rs 58.56 crore in the quarter ended March 2025 as against Rs 43.49 crore during the previous quarter ended March 2024.

For the full year,net profit rose 146.48% to Rs 55.36 crore in the year ended March 2025 as against Rs 22.46 crore during the previous year ended March 2024. Sales rose 28.76% to Rs 268.72 crore in the year ended March 2025 as against Rs 208.70 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	58.56	43.49	35	268.72	208.70	29
OPM %	14.89	6.12	-	19.00	11.05	-
PBDT	11.23	4.93	128	58.30	31.53	85
PBT	8.92	4.53	97	50.17	29.87	68
NP	6.58	3.55	85	55.36	22.46	146